Total Payments
$622,818
2024 Payments
$179,002
Companies
22
Transactions
629
Medicare Patients
24,333
Medicare Billing
$23.1M
Payment Breakdown by Category
Other$421,506 (67.7%)
Consulting$138,873 (22.3%)
Travel$39,679 (6.4%)
Food & Beverage$22,760 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $387,394 | 96 | 62.2% |
| Consulting Fee | $138,873 | 60 | 22.3% |
| Travel and Lodging | $39,679 | 122 | 6.4% |
| Honoraria | $34,112 | 9 | 5.5% |
| Food and Beverage | $22,760 | 342 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $216,988 | 198 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $205,241 | 151 | $0 (2024) |
| Genentech USA, Inc. | $129,747 | 165 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $52,249 | 41 | $0 (2021) |
| Coherus Biosciences Inc. | $7,936 | 10 | $0 (2024) |
| Genentech, Inc. | $5,167 | 10 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $3,408 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $397.16 | 8 | $0 (2024) |
| Allergan, Inc. | $365.41 | 11 | $0 (2021) |
| Alcon Vision LLC | $227.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179,002 | 141 | Apellis Pharmaceuticals, Inc. ($97,200) |
| 2023 | $188,301 | 159 | Apellis Pharmaceuticals, Inc. ($91,694) |
| 2022 | $101,499 | 124 | Regeneron Healthcare Solutions, Inc. ($56,197) |
| 2021 | $26,898 | 36 | Regeneron Healthcare Solutions, Inc. ($19,956) |
| 2020 | $37,739 | 27 | Regeneron Healthcare Solutions, Inc. ($16,190) |
| 2019 | $62,776 | 69 | Novartis Pharmaceuticals Corporation ($38,620) |
| 2018 | $20,984 | 44 | Genentech USA, Inc. ($20,374) |
| 2017 | $5,618 | 29 | Genentech USA, Inc. ($4,843) |
All Payment Transactions
629 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,810.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,448.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Travel and Lodging | Cash or cash equivalent | $223.00 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $9.72 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Apellis Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $5,676.00 | General |
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,534.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,172.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $724.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $362.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,095.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $115.08 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $121.28 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,730.00 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Travel and Lodging | Cash or cash equivalent | $28.14 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $3,402.00 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $112.70 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,902 | 26,931 | $21.5M | $6.4M |
| 2022 | 20 | 6,144 | 22,424 | $18.8M | $5.7M |
| 2021 | 19 | 5,674 | 26,640 | $19.0M | $5.7M |
| 2020 | 13 | 5,613 | 25,599 | $17.4M | $5.3M |
Total Patients
24,333
Total Services
101,594
Medicare Billing
$23.1M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 535 | 5,684 | $11.3M | $3.9M | 34.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 272 | 4,323 | $3.5M | $934,278 | 27.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 783 | 3,359 | $2.6M | $386,495 | 14.9% |
| J3490 | Unclassified drugs | Office | 2023 | 69 | 154 | $748,000 | $326,544 | 43.7% |
| 92134 | Imaging of retina | Office | 2023 | 1,600 | 4,412 | $750,040 | $161,656 | 21.6% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 57 | 785 | $628,000 | $139,663 | 22.2% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 41 | 1,125 | $337,500 | $135,406 | 40.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 681 | 1,318 | $329,500 | $106,508 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 717 | 912 | $273,600 | $68,799 | 25.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 24 | 2,160 | $151,200 | $62,464 | 41.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 27 | 220 | $176,000 | $40,731 | 23.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 326 | 358 | $161,100 | $39,742 | 24.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 188 | 188 | $84,600 | $24,424 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $62,100 | $19,830 | 31.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 582 | 709 | $63,810 | $15,045 | 23.6% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 12 | 12 | $78,000 | $12,878 | 16.5% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 39 | 48 | $72,000 | $10,493 | 14.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 75 | 75 | $22,500 | $8,920 | 39.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 416 | 508 | $43,180 | $6,798 | 15.7% |
| 92250 | Photography of the retina | Office | 2023 | 163 | 193 | $33,775 | $6,343 | 18.8% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 12 | 16 | $40,000 | $4,912 | 12.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $13,800 | $4,645 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $8,050 | $2,660 | 33.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 20 | 34 | $17,000 | $1,916 | 11.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 33 | 43 | $8,580 | $1,814 | 21.1% |
About Dr. Jonathan Jonisch, MD
Dr. Jonathan Jonisch, MD is a Ophthalmology healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467613216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Jonisch, MD has received a total of $622,818 in payments from pharmaceutical and medical device companies, with $179,002 received in 2024. These payments were reported across 629 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($387,394).
As a Medicare-enrolled provider, Jonisch has provided services to 24,333 Medicare beneficiaries, totaling 101,594 services with total Medicare billing of $23.1M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Great Neck, NY
- Active Since 06/24/2008
- Last Updated 05/12/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1467613216
Products in Payments
- Syfovre (Drug) $144,036
- EYLEA (Biological) $126,144
- EYLEA HD (Biological) $93,761
- Lucentis (Biological) $63,478
- Vabysmo (Drug) $37,331
- VABYSMO (Drug) $24,369
- BEOVU (Drug) $16,095
- Cimerli (Biological) $7,969
- SYFOVRE (Drug) $6,804
- Susvimo (Drug) $4,332
- SUSVIMO (Drug) $3,149
- Non-Covered Product (Drug) $489.11
- EYLEA AFLIBERCEPT INJECTION (Biological) $348.27
- OZURDEX (Drug) $291.53
- Izervay (Drug) $127.30
- ACTIVEFOCUS (Device) $125.06
- COMBIGAN (Drug) $123.48
- Clareon (Device) $121.28
- INVELTYS (Drug) $119.32
- AcrySof IQ VIVITY (Device) $106.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Great Neck
Philip Ferrone, Md, MD
Ophthalmology — Payments: $144,807
Ophthalmology $144,807
Kenneth Rosenthal, Md, MD
Ophthalmology — Payments: $72,719
Ophthalmology $72,719
Dr. David Rhee, Md, MD
Ophthalmology — Payments: $13,182
Ophthalmology $13,182
George Tung, Md, MD
Ophthalmology — Payments: $7,576
Ophthalmology $7,576
Juan Romero, Md, MD
Ophthalmology — Payments: $6,910
Ophthalmology $6,910
Richard Russell, M.d, M.D
Ophthalmology — Payments: $5,822
Ophthalmology $5,822